SUSAN EGAN: Open Payments
NPI 1124300702 · NORTH FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 37 payments from 15 companies in 2025. Trend: 2023 $457 · 2024 $990 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $150 |
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| Novo Nordisk Inc | 4 | $88 |
| Lilly USA, LLC | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
Products named: EVENITY, Wegovy, AIRSUPRA, LEQVIO, BREZTRI, INSPIRE, NEXLETOL, MOUNJARO.
Industry payments across MA — which companies pay providers there.
